Researchers at the Illinois Institute of Technology have developed new brain implant technology that aims to help bring sight to the blind. And it landed a grant from the National Institutes of Health to begin clinical trials.
Implant
Researchers Develop Method to Draw Letters and Shapes Directly on the Human Brain
Scientists give blind people ‘sight’ by drawing shapes directly on their brains
UPMC is First to Implant Wireless Retinal Device in the U.S.
Clinical trial will test use of retinal prosthesis to treat advanced age-related macular degeneration.
This Injectable Sensor Constantly Monitors Glaucoma
When someone has glaucoma, there’s always a danger that pressure caused by fluid accumulating within the eye will damage the optic nerve, resulting in blindness. The Injectsense implant is designed to help, by constantly monitoring a recipient’s intraocular pressure or IOP, for short.
First Patient Receives Implant with Implandata’s Eye Pressure Sensor
Medical device company Implandata Ophthalmic Products GmbH (Implandata) announced that the first patient in its international, multi-center, clinical study has been successfully implanted with its novel pressure sensor. This first-in-human clinical study is being conducted to validate the suprachoroidally-placed EYEMATE-SC sensor implant for continual monitoring of intraocular pressure (IOP).
New Glaucoma-Monitoring Implant Now Available in Europe
In recent years, we’ve heard of at least two different implants designed to measure the intraocular pressure in glaucoma patients’ eyes, potentially preventing blindness. Yet another such implant, this one known as Eyemate, recently became commercially available in Europe.
Brain Implant Launching Clinical Trial to Restore Vision to Patients
The device, called the Orion, is a modified version of Second Sight’s current Argus II bionic eye, which involves a pair of glasses outfitted with a camera and an external processor. The U.S. Food and Drug Administration has granted the company a conditional approval for a small study involving five patients at two sites, Baylor College of Medicine and the University of California, Los Angeles. Second Sight still needs to conduct further testing of the device and answer certain questions before starting the trial but hopes to begin enrolling patients in October and do its first implant by the end of the year.
You must be logged in to post a comment.